Sanara MedTech Q4 revenue jumps 119% YoY to $15.3M; full-year revenue up 90% to $45.8M

Sanara MedTech Inc.

2023-FY EPS reported -$1.00 revenue$45,842,845

Net revenue $15.3M in Q4 2022 (up 119% from $7.0M); full-year $45.8M (up 90% from $24.1M).
Operating loss expected $2.0M-$3.5M in Q4 vs $3.4M loss prior year; full-year loss $11.0M-$12.5M vs $7.4M.
Cash and equivalents $9.0M as of December 31, 2022.
Recorded non-cash loss on dissolution of Sanara Pulsar of $1.0M in Q4.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Sanara MedTech Inc. reported the fourth quarter and full year 2022 results: revenue approximately $15.3 million.

Period: the fourth quarter and full year 2022
Revenue: approximately $15.3 million
Result: preliminary results

Exact text from the filing

preliminary results for the fourth quarter and full-year 2022. Selected Fourth Quarter and Full-Year 2022 Preliminary Results (Unaudited) ● Net revenue of approximately $15.3 million for the three months ended December 31, 2022, compared to net revenue of $7.0 million for the three months ended December 31, 2021, which would result in a record net revenue

View on SEC.gov

44 earnings releases filed in the last 30 days. Browse all earnings releases →

Sanara MedTech Inc. filing history →

Source: SEC EDGAR

accession 0001493152-23-005752

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.